OLAPARIB for Prostate cancer: Side Effects & Safety Data
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
There are 973 adverse event reports in the FDA FAERS database where OLAPARIB was used for Prostate cancer.
Most Reported Side Effects for OLAPARIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 4,378 | 24.0% | 4,377 | 104 |
| Malignant neoplasm progression | 1,862 | 10.2% | 368 | 180 |
| Nausea | 1,582 | 8.7% | 129 | 301 |
| Anaemia | 1,455 | 8.0% | 205 | 469 |
| Fatigue | 1,437 | 7.9% | 101 | 241 |
| Off label use | 777 | 4.3% | 212 | 126 |
| Vomiting | 642 | 3.5% | 82 | 187 |
| Drug ineffective | 563 | 3.1% | 67 | 67 |
| Diarrhoea | 514 | 2.8% | 60 | 131 |
| Asthenia | 491 | 2.7% | 51 | 132 |
| Myelodysplastic syndrome | 466 | 2.6% | 114 | 136 |
| Decreased appetite | 450 | 2.5% | 51 | 121 |
| Disease progression | 423 | 2.3% | 56 | 37 |
| Neuropathy peripheral | 411 | 2.3% | 13 | 38 |
| Haemoglobin decreased | 390 | 2.1% | 34 | 117 |
Other Indications for OLAPARIB
Ovarian cancer (5,923)
Breast cancer female (667)
Breast cancer (643)
Ovarian cancer recurrent (515)
Pancreatic carcinoma (475)
Product used for unknown indication (353)
Hormone-refractory prostate cancer (313)
Neoplasm malignant (249)
Fallopian tube cancer (224)
Ovarian epithelial cancer (219)
Other Drugs Used for Prostate cancer
LEUPROLIDE (45,399)
ENZALUTAMIDE (25,954)
RELUGOLIX (18,752)
ABIRATERONE (12,209)
APALUTAMIDE (3,286)
GOSERELIN (2,080)
DEGARELIX (2,035)
BICALUTAMIDE (1,832)
SIPULEUCEL-T (1,720)
DENOSUMAB (1,627)